A Phase 1 trial of twice-yearly Lenacapavir injections recorded zero new HIV infections across 3,200 participants in high-incidence settings, marking a significant breakthrough in HIV prevention. The results suggest a potentially transformative approach to reducing transmission in vulnerable populations globally.
Good News Network · Tuesday, 9 June 2026
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twice a year to people in a high-HIV-incidence country, which […] The post Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection appeared first on Good News Network.
Original source
Read the full article at Good News NetworkShare this story
Volunteer physicians in La Guaira rapidly repurposed a fast-food restaurant to provide medical care following a seismic event, extending healthcare access when conventional facilities were unavailable. The improvised clinic demonstrates community resilience and medical innovation in resource-constrained conditions.
Al Jazeera · 11 Jul
Pakistan's Supreme Court issued comprehensive anti-harassment guidelines for educational institutions and upheld strict penalties against a headmistress who failed to protect female teachers from sexual harassment. The ruling requires all schools to adopt internal harassment policies, establish independent complaint mechanisms, and display codes of conduct across the country.
Dawn Pakistan · 11 Jul
Brazil's Amazon deforestation fell to its lowest level in ten years, reflecting strengthened enforcement against illegal logging and forest clearing. The milestone supports Lula's commitment to eliminate illegal deforestation by 2030, with implications for global climate and biodiversity.
Al Jazeera · 10 Jul
Every Sunday — the week's most uplifting stories, straight to your inbox. No doom, no noise.
No spam. Unsubscribe anytime. GDPR compliant.